Literature DB >> 9540760

Multiple myeloma in younger patients: the role of age as prognostic factor.

A Corso1, C Klersy, M Lazzarino, C Bernasconi.   

Abstract

The presenting features of 356 previously untreated multiple myeloma (MM) patients grouped according to age were analyzed in order (a) to elucidate the possible differences in initial clinical and laboratory features between patients younger than 50 years and the older ones and (b) to statistically assess the prognostic value of the parameters considered, with particular emphasis on the prognostic impact of age. Patients were divided into two groups: group I included 61 patients aged less than 50, group II comprised 295 patients aged 50 or more. No significant differences were found between the two groups in terms of either clinical or laboratory initial characteristics. The treatments adopted and the response to therapy did not differ in the two groups. The prognostic value of presenting features was evaluated for the whole cohort by univariate and multivariate analysis, considering both the observed survival rates and survival rates corrected for the effect of other independent causes of death, using a Poisson model. In both models, calcium level (RR 2.33), performance status (RR 1.83), and creatinine (RR 1.69) maintained their independent negative prognostic value. In contrast, the impact of age was different in the two models. In fact, patients younger than 50 seem to have a better prognosis when the observed survival rates are considered, but they show an increased risk of death when the model takes into account the expected mortality of the underlying population. In conclusion, this study shows that the younger cohort of MM patients has no distinctive initial characteristics with respect to older patients. In multivariate analysis, creatinine levels, calcemia, and performance status show a relevant negative independent prognostic value. Regarding the prognostic impact of age, survival seems to be better among patients younger than 50 than in older patients when the observed survival rates are considered but is significantly worse when the mortality of the corresponding general population, is taken into account.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9540760     DOI: 10.1007/s002770050365

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  8 in total

1.  Multiple Myeloma in Young Adults: A Single Centre Real World Experience.

Authors:  Venkateswar Rao Pydi; Stalin Chowdary Bala; Siva Prasad Kuruva; Rachana Chennamaneni; Meher Lakshmi Konatam; Sadashivudu Gundeti
Journal:  Indian J Hematol Blood Transfus       Date:  2021-02-27       Impact factor: 0.915

Review 2.  Treatment strategies in elderly patients with multiple myeloma: current status.

Authors:  Hang Quach; H Miles Prince; Linda Mileshkin
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

3.  Long-term survival in multiple myeloma: a single-center experience.

Authors:  Francesca Merchionne; Pasquale Procaccio; Franco Dammacco
Journal:  Clin Exp Med       Date:  2008-09-13       Impact factor: 3.984

4.  Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.

Authors:  Heinz Ludwig; Brian G M Durie; Vanessa Bolejack; Ingemar Turesson; Robert A Kyle; Joan Blade; Rafael Fonseca; Meletios Dimopoulos; Kazuyuki Shimizu; Jesus San Miguel; Jan Westin; Jean-Luc Harousseau; Meral Beksac; Mario Boccadoro; Antonio Palumbo; Bart Barlogie; Chaim Shustik; Michele Cavo; Philip R Greipp; Douglas Joshua; Michel Attal; Pieter Sonneveld; John Crowley
Journal:  Blood       Date:  2008-02-11       Impact factor: 22.113

5.  Clinicopathological characteristics of extremely young Korean multiple myeloma patients: therapeutic implications.

Authors:  Junghoon Shin; Youngil Koh; Jeonghwan Youk; Miso Kim; Byung Soo Kim; Chul Won Choi; Hwa Jung Sung; Yong Park; Sung-Soo Yoon; Inho Kim
Journal:  Korean J Intern Med       Date:  2017-06-26       Impact factor: 2.884

6.  Light chain lambda myeloma with fatal AL cardiac amyloidosis in a 21-year-old patient: A case report and review.

Authors:  Vincent Camus; Sydney Dubois; Pierre-Alain Thiébaut; Stéphane Lepretre; Pascal Lenain; Jean-Michel Picquenot; Elena-Liana Veresezan; Arnaud François; Dominique Penther; Fabrice Bauer; Arnaud Jaccard; Fabrice Jardin
Journal:  Clin Case Rep       Date:  2019-05-07

7.  Survival rate of multiple myeloma patients in Indonesia: A retrospective study in multiple myeloma at a single institution.

Authors:  Achmad Fauzi Kamal
Journal:  Ann Med Surg (Lond)       Date:  2019-04-02

8.  A rare case of renal recovery in a young patient with multiple myeloma.

Authors:  Hasan J Salameh; Adeel Ahmad; Tina Kochar
Journal:  Case Rep Nephrol       Date:  2013-03-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.